ROBOSENSE
RoboSense, the leading supplier of LiDAR perception system solutions, and Aidrivers, the UK's leading provider of autonomous mobility solutions for industrial applications announced today a partnership in system integration. Aidrivers will integrate RoboSense Smart LiDAR Sensor System into their own Autonomous Driving Systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190822005468/en/
Aidrivers is delivering a fully autonomous natural navigation system that meets industrial safety standards to seaports, particularly for horizontal transportation, aimed for improving operation efficiency and leading the way in industrial autonomous mobility automation. Their solution can work under all harsh weather conditions by achieving true 3D mapping and localization for precision positioning and situation cognisance and they are using RoboSense 3D LiDAR sensor technology, which collects stable and reliable environment information at near and far distance and under different weather conditions.
“ The performance of RoboSense 3D LiDAR products in harsh weather condition is impressive. We have been testing trailer vehicles under heavy rain and harsh weather conditions and our precision positioning system based on true 3D mapping and localization systems provides accurate localization result. The point cloud data quality in rainy days is excellent and outperforming state of the art.” Aidrivers founder and CEO Dr. Rafiq Swash said, “Aidrivers is dedicated to providing safer, reliable and high-quality Ai enabled autonomous mobility solutions for industrial transportation, and the partnership with RoboSense will give a great confidence to our end users that we are providing autonomous solutions which overcome current challenges of industrial horizontal transportation. Our Ai enabled autonomous solutions are now catering to more industrial transportation industries for both indoor and outdoor in complex environment and weather conditions.”
As one of the pioneer companies to commercialize autonomous driving technology in UK, Aidrivers has been favored by industry giants in the field of autonomous port automation. Aidrivers is deploying a fleet of autonomous prime movers for the world’s leading and busiest port terminals. Aidrivers and SANY have recently partnered to deliver autonomous electric vehicles, specifically industrial horizontal transport solutions, for the Chinese market.
Video about Aidrivers and SANY’s vehicle : https://twitter.com/aidriversltd/status/1141257250629177344?s=20
In these projects, the AI enabled autonomous mobility solutions provided by Aidrivers use RoboSense's 3D LiDARs to collect rich and reliable environment perception data, conduct real-time accurate 3D object detection and tracking. Aidrivers is leading the situation cognisance with AI enabled data fusion to deliver a safer and reliable autonomous driving solutions for complex trailer vehicles under harsh weather.
“Aidrivers is driving the commercialization of autonomous driving technology for industrial transportation on a global scale. RoboSense is very pleased to collaborate with Aidrivers to build safer and robust autonomous driving solutions for major port terminals, and push for the commercialization of this technology.” RoboSense Co-founder and COO, Mark said, “Through in-depth cooperation with Aidrivers, RoboSense will continue to explore and understand the needs of industrial automation, and together with our partners, we will optimize and launch more practical LiDAR perception systems from the application perspective. ”
RoboSense's LiDAR sensors, AI Perception Algorithms and Smart LiDAR Sensor System are widely used in various types of autonomous driving scenarios. Currently, RoboSenses partners covers the world's major autonomous driving technology companies, automotive OEMs, and Tier 1 suppliers. RoboSense has always striven to optimize product performance and reliability to help autonomous driving vehicles to better cope with harsh environments and extreme conditions.
For more information please visit https://aidrivers.ai/ and https://www.robosense.ai/
View source version on businesswire.com: https://www.businesswire.com/news/home/20190822005468/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom